Trial Profile
Clinical Trials Insight: 700047793
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2009
Price :
$35
*
At a glance
- Drugs Diazoxide (Primary) ; HMG-CoA reductase inhibitors (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 11 Aug 2009 New trial record.